This true human plasma-based, nucleosomally fragmented cfDNA product is designed for counting-based NIPT assays. The composition of the cfDNA contains XO (Turner Syndrome), XYY (Jacobs Syndrome), XXY (Klinefelter Syndrome) or XXX (Triple X Syndrome) at 10% fetal fraction.
